Why attend? | Kisaco Research

Why attend?

Microbiome Connect: USA 2024
12-14 November, 2024
BOSTON, USA

Why Attend?

Learn

Explore 3 full days of content & catch 65 industry leading speakers enabling you to stay ahead of the curve. Deep dive into the most need-to-know discovery, clinical, manufacturing and commercial developments across multiple therapeutic areas. Whether you go wild for Women’s Health, are passionate about Oncology or think investing in Neuroscience is a No-Brainer, there’s a session for you.

Connect

Engage in conversations with 250 thought leaders and experts, with 8000 1-2-1 meeting slots to maximize your productivity.

We attract the entire ecosystem from investors to biotechs, and regulators to academics, making this the number 1 place for therapeutic innovation.

Enjoy

The conference programme is just the start. Alongside presentations and partnering opportunities, we’re bringing you a host of interactive & informal activities to make sure you leave feeling energized & enlightened. After a momentous year for the field, take a breath and celebrate industry achievements amongst your peers.

Who's Going? Everyone!

For the last seven years, we’ve been running microbiome events across Europe, North America & Asia – and now we’re bringing the whole community together in Boston. Take a look at who’s joined us before:

Every Challenge. Every Role. We’ve got you covered.

From CEOs to Professors, Investors to Research Scientists, and whatever your modality – there’s a path for you at Microbiome Connect that will enable you to meet your research goals.

We cover:

  • FMT
  • Live Biotherapeutics
  • Genetically Engineered Bacteria
  • Phage
  • Microbiome-Derived Small Molecules
  • Microbiome-Targeting Small Molecules

Biotechs

A great platform to discuss the currently most relevant microbiome topics – a must for microbiome drug developers” – PharmaBiome

Biotechs are at the heart of the event – and as part of Microbiome Connect, you’ll join a global community of microbiome specialists committed to accelerating the development & approval of microbiome-based products to address unmet medical needs.

The landscape of microbiome drug development is constantly evolving, and it’s vital to stay up to date with what’s happening so that you can help shape what’s coming next. From the big-picture trends in regulation, investment and commercialization through to the critical details impacting each stage of the drug development process, our expert contributors will provide valuable insights into how you can move your business forward. Plus, we’ll connect you with the strategic partners you need to help take your innovation from concept to market.


5 Reasons to choose Microbiome Connect

  1. Made with industry, for industry, the agenda is specifically designed to address the strategic and research goals of microbiome biotechs, ensuring you & your team gain the tools, connections & intel you need to fast-track your product development
  2. Be in the room with leading life sciences investors who attend Microbiome Connect to find new portfolio companies – ensuring you access the capital you need for your business to thrive
  3. Spark the connections you need with our Partnering Platform, making it easier than ever to meet the right people for your research & business needs
  4. Sitting in the sweet spot between pure science and pure business, you can trust that you’ll hear the latest data & case studies from top biotechs & academics, as well as network with the most senior decision-makers from across the ecosystem
  5. We know that often your pipeline is built around several disease areas – and instead of needing to attend multiple disease-specific events across the year, you can gather all the insights you need in one place.

REGISTER YOUR INTEREST

Pharma

At Microbiome Connect, we know that the potential of the microbiome to treat disease is almost limitless – making it vital that you stay abreast of the latest research. Whether you’re actively sourcing external innovations or want to look at how you can develop your own microbial therapeutics or biomarkers, you’ll be able to gather the information you need to inform your pipeline strategy.

For 2023, we’ve expanded our disease scope to showcase the breadth of innovation happening in microbiome research, meaning that no matter what therapeutic area you’re prioritizing, you’ll leave with tangible insights and new connections.

Topic Breakdown

Gastrointestinal

1. From BIOMICTRA in Australia to Rebyota & Vowst in the US – after waiting patiently for the first approved product, three came along in swift succession. Explore the professional adoption of the first approved FMT & LBP products

2. Join patient advocates to understand the lengths patients will go to in order to find a potential cure for gastrointestinal illness, and how imperative it is for the microbiome community to keep striving for commercially-available products

Women's Health

1. Hear clinical data on the world’s first multi-strain microbiome therapeutic for bacterial vaginosis, and debate the pros and cons of single-strain vs. multi-strain microbiome therapeutics in terms of product development and health outcomes

2. Unlock the potential of the infant & maternal microbiome through validation of functionally promising microbes as live biotherapeutic treatments & nutritional options in early life

Neuroscience

1. Understand the role of the microbiome in Parkinson’s Disease to develop novel therapeutics with strong efficacy and tolerability profiles

2. Implement genomic and proteomic data to develop novel biomarkers to understand & target the Gut-Brain Axis

Oncology

1. Unpack the transformative potential of the microbiome to treat solid tumours, improving patient response to immune checkpoint inhibitors & overall survival rate in multiple indications

2. Maximize the therapeutic efficacy of your CAR-T products in combination with microbiome therapeutic modulation

Academics

Connect with scientists as passionate about the microbiome as you are – helping you take your innovative research to the next level. Microbiome Connect is the place for microbial innovators from across the globe to come together to networking & learn, with the ultimate goal to truly harness the therapeutic power of the microbiome. Through 40+ scientific sessions, you can stay up to speed with the latest data and technologies impacting both industry & academia.

Do you want to get your work noticed in front of over 400 leading experts in the space?
Showcase your breakthrough research to our audience of experts who can guide you as you look to turn your work from a concept to a commercial product – from synthetic biology to novel organ models, from new clinical results to delivery mechanisms.
The author of the best poster will receive one hour of mentorship time to guide you in making the most of your novel technology.

SUBMIT YOUR ABSTRACT


5 Reasons to choose Microbiome Connect

  1. Our agenda is built after intense research with the community, and is specifically designed to address the strategic & research goals of microbiome leaders, ensuring you gain the connections & intel you need to fast-track your R&D
  2. Be in the room with leading life sciences investors who attend Microbiome Connect to find the next innovation – ensuring you access the capital you need to transition from academia to industry
  3. Spark the connections you need with our Partnering Platform, making it easier than ever to meet the right people for your research & business needs
  4. Sitting in the sweet spot between pure science and pure business, you can trust that you’ll hear the latest data & case studies from top biotechs & academics, as well as network with the most senior decision-makers from across the ecosystem
  5. Thrive in a global microbiome community, with attendees from across the world coming together in Boston to share insights that could transform microbiology


REGISTER YOUR INTEREST

Investors

We firmly believe that microbiome products should be your next investment – and that’s why for 2023, qualified life sciences and healthcare investors can attend Microbiome Connect for free through our Investor Forum.


As part of the Investor Forum, you’ll benefit from:

Investor Lunch

Engage with like-minded investors to exchange knowledge and discuss syndication opportunities at our private, closed-door lunch – bringing together a community of investors with a shared interest in the human microbiome.


Preclinical Showcase

Cut through the noise and hear the hottest preclinical data that’s poised to transform the microbiome therapeutic landscape at our Preclinical Showcase, taking the guesswork out of which companies should be on your radar.


Therapeutic Coverage

By covering the breadth of the microbiome industry, you’ll be able to build your conference agenda around your current investment priorities – no matter the disease area or modality.

1-2-1 Partnering

An investor who receives complimentary registration is expected to participate in the 1-2-1 partnering, with at least two meetings secured through the system with microbiome companies – allowing you to meet the leading biotechs in the space actively looking for early and late-stage investment in an efficient way. Our in-depth registration forms allow you to identify & target the most suitable prospects for you based on stage of development, strategic goals and therapeutic preferences.